Lilly’s Mounjaro (tirzepatide) demonstrated cardiovascular protection in a head-to-head trial Read more
Lilly launches Mounjaro (tirzepatide), offers new treatment option for obesity and type 2 diabetes Read more
US FDA approves Jardiance to treat adults living with heart failure with reduced ejection fraction Read more